- Home
- Taking on heart disease
Innovating in Health&Care
Do you know what heart failure is? (Hint: It’s probably not what you think)
Learn about the advances Johnson & Johnson is making to help turn heart failure into heart recovery for the millions of adults in the U.S. living with the condition, which occurs when the heart muscle isn’t able to pump blood as well as it should.
Meet the medical engineer behind the innovative heart pump that revolutionized cardiac health
Drawing on his fascination with airplane technology, Thorsten Siess, Ph.D., came up with an idea that became the Impella heart pump. Now, 25 years since it entered the market, this groundbreaking device has helped more than 400,000 patients recover from heart injuries.
“There’s a growing need to expand the CLTI treatment toolbox”
With new innovations, surgeons are able to treat lesions that were, historically, too challenging to cross.
Inside the all-female coronary interventions trial
EMPOWER CAD is a first-of-its-kind study to determine the effectiveness of IVL in women to address a gender gap in coronary artery disease outcomes—and empower female clinicians along the way.
What’s the difference between a heart attack and cardiac arrest?
Both are life-threatening heart-health emergencies, but they are two distinct conditions with different causes and treatment. Here’s what a cardiologist wants you to know.
Ask an electrophysiologist: What roles do PFA and RFA play in the treatment of AFib?
Both are types of cardiac ablation, but are distinct in a few key ways. An expert weighs in on when and how they can be harnessed.
More from Johnson & Johnson
Using your own cells to fight cancer
Cell therapy is bringing the world one step closer to eliminating cancer. Here’s how Johnson & Johnson is moving this cutting-edge therapy forward.
Moving toward a more personalized approach to treating depression
The World Health Organization predicts that depression will be the leading cause of disability across the globe by 2030. Learn how Johnson & Johnson is on a mission to change that.
“Our goal is a solution for every bladder cancer patient”
Meet Christopher Cutie, M.D., the Johnson & Johnson scientist who’s helping change the treatment landscape for people with bladder cancer, the tenth most common cancer in the world.